P3.01-85 Real-World Gefitinib 1st Line Treatment of Patients with Advanced NSCLC and EGFR Mutations - Serbian Single Center Experience

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2018年第10期|共1页
• 作者

  D. Radosavljevic; J. Spasic; M. Ristic; V. Nikolic; N. Nikolic; N. Stanic; F. Djordjevic; D. Gavrilovic;

  展开▼
• 作者单位

  Clinic for Medical Oncology Institute for Oncology and Radiology of Serbia;

  Clinic for Medical Oncology Institute for Oncology and Radiology of Serbia;

  Clinic for Medical Oncology Institute for Oncology and Radiology of Serbia;

  Clinic for Medical Oncology Institute for Oncology and Radiology of Serbia;

  Clinic for Medical Oncology Institute for Oncology and Radiology of Serbia;

  Clinic for Medical Oncology Institute for Oncology and Radiology of Serbia;

  Clinic for Medical Oncology Institute for Oncology and Radiology of Serbia;

  Clinic for Medical Oncology Institute for Oncology and Radiology of Serbia;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词